Wittering Capital seals reverse takeover of Grafta Nanotech
What's the deal? Wittering Capital Corp. has signed a definitive amalgamation agreement to acquire Grafta NanotechDealroom has a profile for this one. Try Dealroom → Inc., an Alberta-incorporated nanotech company. The deal, dated July 10, 2026, follows a non-binding letter of intent from October 29, 2025.
How is it structured? The transaction is a three-cornered amalgamation under Alberta's Business Corporations Act. Wittering's wholly owned subsidiary, 2794296 Alberta Ltd., will merge with Grafta to form Amalco, which becomes a wholly owned subsidiary of the resulting issuer.
What are the terms? Wittering will consolidate its shares on a 1:2 basis, and each Grafta share will convert into one post-consolidation Wittering share. Grafta's warrants will be exercisable at 25 cents per share until January 13, 2027, while its options carry a 20-cent exercise price until February 27, 2029.
Grafta paid a finder's fee to Ace CapitalDealroom has a profile for this one. Try Dealroom → of 90,000 shares, 350,000 options, and $15,000 in cash under a capital markets advisory agreement.
What changes? The resulting issuer plans to rename itself Grafta Nanotech Corp. and list as a Tier 2 industrial issuer on the TSX Venture Exchange under the symbol GFTA. Grafta's shareholders will join the resulting issuer, while Wittering shareholders keep their equity on a post-consolidation basis.
What could go wrong? The deal remains conditional on completing financings in both companies and securing approval from the TSX Venture Exchange. No advances have been made from Wittering to Grafta ahead of closing.
The signal: The transaction is a reverse takeover that gives Grafta a public listing without a traditional initial public offering. It reflects the continued use of capital pool structures on Canada's venture exchange to bring early-stage industrial and technology companies to market.
Read more: Stockwatch
Image credit: brewbooks
